These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 31517281)
1. Hemelryck SV; Dewulf J; Niekus H; van Heerden M; Ingelse B; Holm R; Mannaert E; Langguth P Int J Pharm X; 2019 Dec; 1():100016. PubMed ID: 31517281 [TBL] [Abstract][Full Text] [Related]
2. In Vitro Evaluation of Poly(lactide-co-glycolide) In Situ Forming Gels for Bedaquiline Fumarate Salt and Pharmacokinetics Following Subcutaneous Injection in Rats. Van Hemelryck S; Wens R; van Poppel H; Luijks M; Shahidi K; Marczak M; Kahnt A; Holm R; Mannaert E; Langguth P Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452192 [TBL] [Abstract][Full Text] [Related]
3. Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur. Zhang L; Parsons DL; Navarre C; Kompella UB J Control Release; 2002 Dec; 85(1-3):73-81. PubMed ID: 12480313 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of an in situ forming gel system for sustained delivery of Florfenicol. Yu ZG; Geng ZX; Liu TF; Jiang F J Vet Pharmacol Ther; 2015 Jun; 38(3):271-7. PubMed ID: 25287575 [TBL] [Abstract][Full Text] [Related]
5. Mixed Micellar Gel of Poloxamer Mixture for Improved Solubilization of Poorly Water-Soluble Ibuprofen and Use as Thermosensitive In Situ Gel. Hirun N; Kraisit P; Santhan S Pharmaceutics; 2024 Aug; 16(8):. PubMed ID: 39204400 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide. Erfani Jabarian L; Rouini MR; Atyabi F; Foroumadi A; Nassiri SM; Dinarvand R Eur J Pharm Sci; 2013 Jan; 48(1-2):87-96. PubMed ID: 23131800 [TBL] [Abstract][Full Text] [Related]
7. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle. Sherif S; Bendas ER; Badawy S Eur J Pharm Biopharm; 2014 Feb; 86(2):251-9. PubMed ID: 24056055 [TBL] [Abstract][Full Text] [Related]
8. In-situ gel injection of poloxamer-based metamizole provides long-acting antipyretic effects. Wang Y; Li D; Li X; Ren D; Zhang W; Shu G; Lin J; Li H; Xu F; Peng G; Fu H Drug Deliv Transl Res; 2024 Jun; ():. PubMed ID: 38896348 [TBL] [Abstract][Full Text] [Related]
9. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies. M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392 [TBL] [Abstract][Full Text] [Related]
10. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity. Jones DS; Bruschi ML; de Freitas O; Gremião MP; Lara EH; Andrews GP Int J Pharm; 2009 May; 372(1-2):49-58. PubMed ID: 19429268 [TBL] [Abstract][Full Text] [Related]
11. Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation. Cafaggi S; Russo E; Caviglioli G; Parodi B; Stefani R; Sillo G; Leardi R; Bignardi G Eur J Pharm Sci; 2008 Sep; 35(1-2):19-29. PubMed ID: 18598763 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels. He W; Guo X; Feng M; Mao N Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520 [TBL] [Abstract][Full Text] [Related]
13. In vitro characterization of a formulation of butorphanol tartrate in a poloxamer 407 base intended for use as a parenterally administered slow-release analgesic agent. Laniesse D; Smith DA; Knych HK; Mosley C; Guzman DS; Beaufrère H Am J Vet Res; 2017 Jun; 78(6):677-687. PubMed ID: 28541144 [TBL] [Abstract][Full Text] [Related]
14. Cyclodextrin-poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B. Jansook P; Pichayakorn W; Muankaew C; Loftsson T Drug Dev Ind Pharm; 2016 Sep; 42(9):1446-54. PubMed ID: 26765786 [TBL] [Abstract][Full Text] [Related]
15. Poloxamer 407 Based Gel Formulations for Transungual Delivery of Hydrophobic Drugs: Selection and Optimization of Potential Additives. Ullah KH; Raza F; Munawar SM; Sohail M; Zafar H; Zafar MI; Ur-Rehman T Polymers (Basel); 2021 Sep; 13(19):. PubMed ID: 34641190 [TBL] [Abstract][Full Text] [Related]
16. Poloxamer-based in situ hydrogels for controlled delivery of hydrophilic macromolecules after intramuscular injection in rats. Zhang K; Shi X; Lin X; Yao C; Shen L; Feng Y Drug Deliv; 2015 May; 22(3):375-82. PubMed ID: 24601854 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of butorphanol tartrate in a poloxamer P407 gel formulation administered to orange-winged Amazon parrots (Amazona amazonica). Mikoni N; Sanchez-Migallon Guzman D; Knych H; Douglas JM; Paul-Murphy JR Am J Vet Res; 2022 Jun; 83(8):. PubMed ID: 35895783 [TBL] [Abstract][Full Text] [Related]
18. Sustained release formulations of rhVEGF₁₆₅ produce a durable response in a murine model of peripheral angiogenesis. Daugherty AL; Rangell LK; Eckert R; Zavala-Solorio J; Peale F; Mrsny RJ Eur J Pharm Biopharm; 2011 Jun; 78(2):289-97. PubMed ID: 21426936 [TBL] [Abstract][Full Text] [Related]
19. Poloxamer-Based Thermoreversible Gel for Topical Delivery of Emodin: Influence of P407 and P188 on Solubility of Emodin and Its Application in Cellular Activity Screening. Ban E; Park M; Jeong S; Kwon T; Kim EH; Jung K; Kim A Molecules; 2017 Feb; 22(2):. PubMed ID: 28178225 [TBL] [Abstract][Full Text] [Related]
20. A Novel Thermoresponsive Gel as a Potential Delivery System for Lipoxin. Wang B; Shao J; Jansen JA; Walboomers XF; Yang F J Dent Res; 2019 Mar; 98(3):355-362. PubMed ID: 30403904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]